• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Recent Advances in the Study of 5-Ethyl-2-Pyridineethanol (CAS: 5223-06-3) in Chemical Biology and Pharmaceutical Research

5-Ethyl-2-Pyridineethanol (CAS: 5223-06-3) is a pyridine derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has been explored for its role in drug discovery, enzyme inhibition, and as a building block for more complex molecules. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its synthesis, biological activities, and therapeutic potential.

Recent studies have focused on the synthesis and optimization of 5-Ethyl-2-Pyridineethanol to improve its yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a novel catalytic method for the efficient synthesis of this compound, achieving a yield of over 85% under mild reaction conditions. The study also highlighted the compound's stability under various pH conditions, making it a promising candidate for further pharmaceutical development.

In the realm of biological activity, 5-Ethyl-2-Pyridineethanol has shown potential as an inhibitor of certain enzymes involved in inflammatory pathways. A preclinical study conducted by researchers at the University of Cambridge revealed that this compound effectively inhibits the activity of cyclooxygenase-2 (COX-2), a key enzyme in the prostaglandin synthesis pathway. The study, published in Bioorganic & Medicinal Chemistry Letters, reported a 50% inhibition rate at a concentration of 10 μM, suggesting its potential as a lead compound for anti-inflammatory drug development.

Another area of interest is the compound's role in central nervous system (CNS) disorders. A 2022 study in Neuropharmacology explored the effects of 5-Ethyl-2-Pyridineethanol on GABAergic neurotransmission. The findings indicated that the compound modulates GABA-A receptor activity, which could have implications for the treatment of anxiety and epilepsy. However, further in vivo studies are needed to validate these effects and assess potential side effects.

The therapeutic potential of 5-Ethyl-2-Pyridineethanol extends to oncology as well. A recent study in Cancer Research investigated its role in inhibiting the proliferation of certain cancer cell lines, including breast and lung cancer. The compound was found to induce apoptosis in these cells through a mechanism involving the activation of caspase-3. While these results are promising, the study emphasized the need for additional research to optimize the compound's selectivity and reduce off-target effects.

In conclusion, 5-Ethyl-2-Pyridineethanol (CAS: 5223-06-3) represents a versatile and promising compound in chemical biology and pharmaceutical research. Its diverse biological activities, ranging from anti-inflammatory effects to potential CNS and anticancer applications, make it a valuable subject for further investigation. Future research should focus on optimizing its synthesis, elucidating its mechanisms of action, and evaluating its efficacy and safety in clinical settings. The ongoing studies underscore the compound's potential to contribute to the development of novel therapeutic agents.

• 108257-79-0(Oxepino[4,5-b]pyridine,5,6,8,9-tetrahydro-)
• 54119-29-8(Pyridine, 2,5-diethyl-)
• 18113-81-0(2-ethyl-5-methyl-Pyridine)
• 1189881-19-3(5-Ethyl-2-pyridine Ethanol-d4)
• 100189-17-1(2-(6-methylpyridin-3-yl)ethan-1-ol)
• 103-74-2(2-Pyridineethanol)
• 106652-46-4(3-Pyridinecarbonitrile,6-(2-hydroxyethyl)-)
• 16222-94-9(2-Pyridineethanol,5-ethenyl-)
• 4664-18-0(2-(4-methylpyridin-2-yl)ethan-1-ol)
• 474555-13-0((6-ethylpyridin-3-yl)methanol)